Position history for CITADEL ADVISORS LLC's holdings in DIANTHUS THERAPEUTICS INC
CITADEL ADVISORS LLC holds 1.6M shares of DNTH (DIANTHUS THERAPEUTICS INC), worth $135.2M as of 2026-Q1. The position was increased (+50.7% shares). DNTH represents 0.0% of CITADEL ADVISORS LLC's portfolio.
Current Value
$135.2M
Current Shares
1.6M
Total Value Change
+$135.2M
Total Shares Change
+1.6M
Other major holders of DNTH: FMR LLC, BlackRock, Inc., RA CAPITAL MANAGEMENT, L.P.
Increased |
| 1.6M |
+50.7% |
| $135.2M |
| 0.0% |
| $55.39 |
42 |
| 2025-Q4 | Increased | 1.1M | +5.5% | $44.1M | 0.0% | $40.96 | 31 |
| 2025-Q3 | Increased | 1M | +52.4% | $39.9M | 0.0% | $39.55 | 41 |
| 2025-Q2 | Increased | 665,044 | +41.2% | $12.4M | 0.0% | $17.63 | 37 |
| 2025-Q1 | Increased | 470,880 | +11.6% | $8.5M | 0.0% | $19.99 | 31 |
| 2024-Q4 | Increased | 422,038 | +611.7% | $9.2M | 0.0% | $21.50 | 45 |
| 2024-Q3 | New | 59,301 | - | $1.6M | 0.0% | $27.24 | 35 |
| 2024-Q2 | Exited | 0 | -100.0% | $0 | 0.0% | $25.88 | 0 |